Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiharu Nagatsu

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|March 21, 2015
The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymesToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2020
Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?Toshiharu Nagatsu
Neurotoxicology|December 31, 2003
Progress in monoamine oxidase (MAO) research in relation to genetic engineeringToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|August 10, 2016
Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospectsToshiharu Nagatsu
Fujita Medical Journal|March 2, 2022
Remembering Keisuke Fujita, M.D., Ph.D., President and Founder of Fujita Health University, and his contributions to medical science and educationToshiharu Nagatsu
Neurotoxicology and Teratology|August 30, 2002
Amine-related neurotoxins in Parkinson's disease: past, present, and futureToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|December 7, 2019
Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?Toshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 2023
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overviewToshiharu Nagatsu
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Identification of the causative gene for Segawa's disease]Hiroshi Ichinose, Toshiharu Nagatsu
Toxicology|August 24, 2005
Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slicesYoko Hirata, Toshiharu Nagatsu
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|March 21, 2015
The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymesToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2020
Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?Toshiharu Nagatsu
Neurotoxicology|December 31, 2003
Progress in monoamine oxidase (MAO) research in relation to genetic engineeringToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|August 10, 2016
Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospectsToshiharu Nagatsu
Fujita Medical Journal|March 2, 2022
Remembering Keisuke Fujita, M.D., Ph.D., President and Founder of Fujita Health University, and his contributions to medical science and educationToshiharu Nagatsu
Neurotoxicology and Teratology|August 30, 2002
Amine-related neurotoxins in Parkinson's disease: past, present, and futureToshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|December 7, 2019
Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?Toshiharu Nagatsu
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 2023
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overviewToshiharu Nagatsu
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Identification of the causative gene for Segawa's disease]Hiroshi Ichinose, Toshiharu Nagatsu
Toxicology|August 24, 2005
Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slicesYoko Hirata, Toshiharu Nagatsu
Pageof 7